nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.02.2015 | Original Article

Effectiveness of chamomile tea on glycemic control and serum lipid profile in patients with type 2 diabetes

verfasst von: M. Rafraf, M. Zemestani, M. Asghari-Jafarabadi

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Aims

This study aimed at assessing the effects of chamomile tea consumption on glycemic control and serum lipid profile in patients with type 2 diabetes mellitus (T2DM).

Methods

This single-blind randomized controlled clinical trial was conducted on 64 individuals with T2DM (males and females) aged between 30 and 60 years. The intervention group (n = 32) consumed chamomile tea (3 g/150 mL hot water) three times per day immediately after meals for 8 weeks. The control group (n = 32) followed a water regimen for the same intervention period. Fasting blood samples, anthropometric measurements, and 3-day, 24-h dietary recalls were collected at the baseline and at the end of the trial. Data were analyzed by independent t test, paired t test, Pearson correlation test, and analysis of covariance.

Results

Chamomile tea significantly decreased concentration of HbA1C (p = 0.03), serum insulin levels (p < 0.001), homeostatic model assessment for insulin resistance (p < 0.001), total cholesterol (p = 0.001), triglyceride (p < 0.001), and low-density lipoprotein cholesterol (p = 0.05) compared with control group. No significant changes were shown in serum high-density lipoprotein cholesterol levels in both groups.

Conclusion

Chamomile tea has some beneficial effects on glycemic control and serum lipid profile in T2DM patients.

IDF (2009) Diabetes and impaired glucose tolerance. Global burden: prevalence and projections 2010 and 2030. http://www.idf.org/diabetesatlas/diabetes-and-impaired-glucose-tolerance

IDF (2011) Diabetes atlas, 5th edn. 2011 International Diabetes Federation. www.idf.org/diabetesatlas/papers

Nolte MS, Karam JH (2004) Pancreatic hormones and antidiabetic drugs. Basic Clin Pharmacol 9:693–715

Holman RR, Turner RC (1991) Oral agent and insulin in the treatment of NIDDM. In: Pickup J, Williams G (eds) Textbook of diabetes. Blackwell Publication, Oxford, pp 467–469

Jouad H, Haloui M, Rhiouani H, Elhilaly J, Eddouks M (2001) Ethnopharmacological survey of medicinal plants used or the treatment of diabetes, cardiac and renal diseases in the North centre region of Morocco. J Ethnopharmacol 77:175–182PubMedCrossRef

Li WL, Zheng HC, Bukuru J, De Kimpe N (2004) Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 92:1–21PubMedCrossRef

Franke R, Schilcher H (2005) Chamomile: industrial profiles (medicinal and aromatic plants). CRC Press, Boca Raton

McKay DL, Blumberg JB (2006) A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res 20:519–530PubMedCrossRef

Srivastava JK, Gupta S (2007) Antiproliferative and apoptotic effects of chamomile extract in various human cancer cells. J Agric Food Chem 55:9470–9478PubMedCrossRef

10.

Wazaify M, Afifi UF, El-Khateeb M, Ajlouni K (2011) Complementary and alternative medicine use among Jordanian patients with diabetes. Complement Ther Clin Pract 17:71–75PubMedCrossRef

11.

Azzi R, Djaziri R, Lahfa F, Sekkal FZ, Benmehdi H, Belkacem N (2012) Ethnopharmacological survey of medicinal plants used in the traditional treatment of diabetes mellitus in the North Western and South Western Algeria. J Med Plants Res 6:2041–2050

12.

Kato A, Minoshima Y, Yamamoto J, Adachi I, Watson AA, Nash RJ (2008) Protective effects of dietary chamomile tea on diabetic complications. J Agric Food Chem 56:8206–8211PubMedCrossRef

13.

Eddouks M, Lemhadri A, Zeggwagh NA, Michel JB (2005) Potent hypoglycaemic activity of the aqueous extract of Chamaemelum nobile in normal and streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 67:189–195PubMedCrossRef

14.

Ramadan KS, Emam MA (2012) Biochemical evaluation of antihyperglycemic and antioxidative effects of matricaria chamomilla leave extract studied in streptozotocin-induced diabetic rats. Int J Res Manag Technol 2:298–302

15.

Ganzera M, Schneider P, Stuppner H (2006) Inhibitory effects of the essential oil of chamomile (Matricaria recutita) and its major constituents on human cytochrome P450 enzymes. Life Sci 78:856–861PubMedCrossRef

16.

Baser KH, Demirci B, Iscan G, Hashimoto T, Demirci F, Noma Y, Asakawa Y (2006) The essential oil constituents and antimicrobial activity of Anthemis aciphylla BOISS. var. discoidea BOISS. Chem Pharm Bull 54:222–225PubMedCrossRef

17.

Panda S, Kar A (2007) Apigenin (4′,5,7-trihydroxyflavone) regulates hyperglycaemia, thyroid dysfunction and lipid peroxidation in alloxan induced diabetic mice. J Pharm Pharmacol 59:1543–1548PubMedCrossRef

18.

Cemek M, Kaga S, Simsek N, Buyukokuroglu ME, Konuk M (2008) Antihyperglycemic and antioxidative potential of Matricaria chamomilla L. in streptozotocin-induced diabetic rats. J Nat Med 62:284–293PubMedCrossRef

19.

Darvishpadok A, Azemi M, Namjoyan F, Khodayar M, Ahmadpour F, Panahi M (2012) Effect of Matricaria chamomilla L. on blood glucose and glycosylated hemoglobin in female fertile diabetic rats. Res Pharm Sci 7:19

20.

De Lima VLAG, Melo ED, Lima DES (2004) Total phenolic content in Brazilian teas. Brazil J Food Technol 7(2):187–190

21.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef

22.

Ozkaya M, Cakal E, Ustun Y, Engin-Ustan Y (2010) Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome. Fertil Steril 93:880–884PubMedCrossRef

23.

Najla OA, Olfat AK, Kholoud SR, Enas ND, I Hanan SA (2012) Hypoglycemic and biochemical effects of Matricaria Chamomilla leave extract in streptozotocin-induced diabetic rats. J Health Sci 2:42–48

24.

Weidner C, Wowro SJ, Rousseau M, Freiwald A, Kodelja V, Abdel-Aziz H, Sauer S (2013) Antidiabetic effects of chamomile flowers extract in obese mice through transcriptional stimulation of nutrient sensors of the peroxisome proliferator-activated receptor (PPAR) family. PLoS One 8:1–16

25.

Berger J, Moller DE (2002) The mechanisms of action of PPARs. Ann Rev Med 53:409–435PubMedCrossRef

26.

Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK (2006) International Union of Pharmacology. LXI. Peroxisome proliferator activated receptors. Pharmacol Rev 58:726–741PubMedCrossRef

27.

Lehrke M, Lazar MA (2005) The many faces of PPARgamma. Cell 123:993–999PubMedCrossRef

28.

Spiegelman BM (1998) PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507–514PubMedCrossRef

29.

Kim J, Jobin C (2005) The flavonoid luteolin prevents lipopolysaccharide-induced NFkappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 115:375–387PubMedCentralPubMedCrossRef

30.

Ding L, Daozhong J, Xiaoli C (2010) Luteolin enhances insulin sensitivity via activation of PPARγ transcriptional activity in adipocytes. J Nutr Biochem 21:941–947PubMedCrossRef

31.

Xita N, Tsatsoulis A (2012) Adiponectin in diabetes mellitus. Curr Med Chem 19:5451–5458PubMedCrossRef

32.

Lihn A, Pedersen SB, Richelsen B (2005) Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 6:13–21PubMedCrossRef

33.

Al-Jubouri HHF, Al-Jalil BH, Farid I, Jasim F, Wehbi S (1990) The effect of chamomile on hyperlipidemias in rats. J Fac Med Baghdad 32:5–11

34.

Mather KJ, Helmut OS, Alain D (2013) Insulin resistance in the vasculature. J Clin Invest 123:1003–1004PubMedCentralPubMedCrossRef

35.

Zavaroni I, Dall’Aglio E, Alpi O, Bruschi F, Bonora E, Pezzarossa A, Butturini U (1985) Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55:259–266PubMedCrossRef

36.

Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL (1983) Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 118:326–337PubMed

37.

Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK (1988) Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 37:338–345PubMedCrossRef

38.

Kalra A, Sreekumaran N, Lavanya R (2006) Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome. Indian J Med Sci 60:11

39.

Reaven GM, Lerner RL, Stern MP, Farquhar JW (1967) Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 46:1756–1767PubMedCentralPubMedCrossRef

40.

Laws A, Reaven GM (1992) Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Intern Med 231:25–30PubMedCrossRef

41.

Goldberg IJ (1996) Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37:693–707PubMed

42.

Fruchart JC, Staels B, Duriez P (2001) The role of fibric acids in atherosclerosis. Curr Atheroscler Rep 3:83–92PubMedCrossRef

43.

Harrington WW, Britt SC, Wilson JG, Milliken NO, Binz JG, Lobe DC, Oliver WR, Lewis MC, Oliver WR, Ignar DM (2007) The effect of PPARα, PPARδ, PPARγ, and PPARpan agonists on bodyweight, bodymass, and serum lipid profiles in diet-induced obese AKR/J mice. PPAR Res: 1–13

Titel: Effectiveness of chamomile tea on glycemic control and serum lipid profile in patients with type 2 diabetes
verfasst von: M. Rafraf
M. Zemestani
M. Asghari-Jafarabadi
Publikationsdatum: 01.02.2015
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 2/2015
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-014-0170-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Aims

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2015

Effect of hydrocortisone replacement therapy on body mass index after pituitary surgery

A population-based study of the relationship between idiopathic hirsutism and metabolic disturbances

Update on a new controversy in endocrinology: isolated maternal hypothyroxinemia

King Ariarathes IV of Cappadocia: coins reveal enlarged thyroid (188 BC)

Rare diseases in clinical endocrinology: a taxonomic classification system